DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia

Linea Natalie Toksvang; Kathrine Grell; Stine Nygaard Nielsen; Jacob Nersting; Daniel Murdy; Anthony V Moorman; Ajay Vora; Kjeld Schmiegelow

doi:10.1038/s41375-021-01420-0

DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia

Linea Natalie Toksvang, Kathrine Grell, Stine Nygaard Nielsen, Jacob Nersting, Daniel Murdy, Anthony V Moorman, Ajay Vora, Kjeld Schmiegelow^*

^*Corresponding author af dette arbejde

Afdeling for Børn og Unge

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	36
Udgave nummer	2
Sider (fra-til)	555-557
Antal sider	3
ISSN	0887-6924
DOI	https://doi.org/10.1038/s41375-021-01420-0
Status	Udgivet - feb. 2022

Adgang til dokumentet

10.1038/s41375-021-01420-0

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{396b01e4233a4438a33a0088e1b9e597,

title = "DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia",

keywords = "Antimetabolites, Antineoplastic/adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Hepatic Veno-Occlusive Disease/chemically induced, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Prognosis, Thioguanine/adverse effects",

author = "Toksvang, {Linea Natalie} and Kathrine Grell and Nielsen, {Stine Nygaard} and Jacob Nersting and Daniel Murdy and Moorman, {Anthony V} and Ajay Vora and Kjeld Schmiegelow",

year = "2022",

month = feb,

doi = "10.1038/s41375-021-01420-0",

language = "English",

volume = "36",

pages = "555--557",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia

AU - Toksvang, Linea Natalie

AU - Grell, Kathrine

AU - Nielsen, Stine Nygaard

AU - Nersting, Jacob

AU - Murdy, Daniel

AU - Moorman, Anthony V

AU - Vora, Ajay

AU - Schmiegelow, Kjeld

PY - 2022/2

Y1 - 2022/2

KW - Antimetabolites, Antineoplastic/adverse effects

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Hepatic Veno-Occlusive Disease/chemically induced

KW - Humans

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Prognosis

KW - Thioguanine/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=85115211552&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01420-0

DO - 10.1038/s41375-021-01420-0

M3 - Letter

C2 - 34535761

SN - 0887-6924

VL - 36

SP - 555

EP - 557

JO - Leukemia

JF - Leukemia

IS - 2

ER -